About Molecular NeuroImaging
Molecular NeuroImaging is a company based in New Haven (United States) founded in 2000 was acquired by Invicro in February 2016.. The company has 161 employees as of December 31, 2017. Molecular NeuroImaging offers products and services including Imaging Core Lab, Clinical Adjudication, eClinical, and Preclinical Imaging. Molecular NeuroImaging operates in a competitive market with competitors including Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others.
- Headquarter New Haven, United States
- Employees 161 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Molecular Neuroimaging Llc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Molecular NeuroImaging
Molecular NeuroImaging offers a comprehensive portfolio of products and services, including Imaging Core Lab, Clinical Adjudication, eClinical, and Preclinical Imaging. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides high-quality imaging data for global clinical trials
Independent review of trial event assessments for accuracy
Offers randomization and supply management solutions
Supports study designs in pharmaceutical R&D processes
Funding Insights of Molecular NeuroImaging
- Total Funding Total Funding
- Total Rounds 5
- Last Round Grant — $3.0M
-
First Round
First Round
(17 Jul 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2014 | Amount | Grant - Molecular NeuroImaging | Valuation |
investors |
|
| Aug, 2009 | Amount | Grant - Molecular NeuroImaging | Valuation |
investors |
|
| Feb, 2009 | Amount | Grant - Molecular NeuroImaging | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Molecular NeuroImaging
Molecular NeuroImaging has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, Invicro and OSTI.GOV. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
Scientific and technical information is managed and disseminated by OSTI.GOV.
|
Founded Year | Domain | Location | |
|
Provide contract research imaging services and software
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Molecular NeuroImaging
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Molecular NeuroImaging
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Molecular Neuroimaging Comparisons
Competitors of Molecular NeuroImaging
Molecular NeuroImaging operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Thermo Fisher Scientific, Siemens Healthineers, Merck and Quanterix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| domain | founded_year | HQ Location |
Electron microscopy services and microanalysis instruments are provided.
|
|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Molecular NeuroImaging
When was Molecular NeuroImaging founded?
Molecular NeuroImaging was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Where is Molecular NeuroImaging located?
Molecular NeuroImaging is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
How many employees does Molecular NeuroImaging have?
As of Dec 31, 2017, the latest employee count at Molecular NeuroImaging is 161.
What does Molecular NeuroImaging do?
Founded in 2000 and based in New Haven, United States, Molecular NeuroImaging operates in the neuroimaging sector, focusing on PET and SPECT biomarkers for drug development and clinical research in neurodegenerative and neuropsychiatric disorders. Services include radioligand development, manufacturing, imaging study design for Phases 1-4 trials, multi-site coordination, and quantitative image analysis. Expertise covers 22 CNS targets and conditions such as Alzheimers disease, Parkinsons disease, and multiple sclerosis.
Who are the top competitors of Molecular NeuroImaging?
Molecular NeuroImaging's top competitors include Thermo Fisher Scientific, Biocare Medical and Merck.
What products or services does Molecular NeuroImaging offer?
Molecular NeuroImaging offers Imaging Core Lab, Clinical Adjudication, eClinical, and Preclinical Imaging.